Topic: HPV, Cervical cancer prevention
The aim of this bi-national study was to compare and contrast the knowledge, beliefs, and practices regarding human papillomavirus (HPV) vaccination among mothers of vaccine-eligible girls, health care providers, and program administrators at two community clinics in Oxnard, California, and two Mexican Social Security Institute (IMSS) clinics in Cuernavaca, Mexico. Although mothers in the US had less knowledge and more negative attitudes toward the vaccine than their counterparts in Mexico, vaccine uptake rates were higher in the US (49% vs. 40%). US mothers were more likely to have discussed and been offered the HPV vaccine by a clinician than mothers in Mexico. In multivariate analyses, having been offered the HPV vaccine was the most important predictor of vaccine uptake.
Research Team:
Roshan Bastani, PhD
Yvonne Flores, PhD, MPH
Thomas Belin, Ph.D.
Community Partner: Two Clinicas del Camino Real clinics: (1) the Oxnard Clinic and (2) the Maravilla Clinic, both in Oxnard, CA
Study Population: Mexican women 18–65 years of age who are the mothers or medical decision-makers for girls who are HPV vaccine eligible
Funding Source: Programa de Investigación en Migracion y Salud (PIMSA) 2010-11 funding cycle and UCLA
Publications:
- Wentzell E, Flores YN, Salmerón J, Bastani R. Factors Influencing Mexican Women’s Decisions to Vaccinate Daughters Against HPV in the United States and Mexico. Family and Community Health. 2016;39(4):310-9. PMID: 27536936.
- Flores YN, Salmerón J, Glenn BA, Lang CM, Chang LC, Bastani R. Clinician offering is a key factor associated with HPV vaccine uptake among Mexican mothers in the USA and Mexico: a cross-sectional study. International Journal of Public Health. 2019;64(3):323-332. PMCID: PMC6451874.